Blood cell activation as an indicator of prothrombogenesis in polycythemia vera: Case control study
BACKGROUND: Polycythemia vera (PV) is a chronic myeloproliferative stem cell disease usually combined with JAK2 mutation. Active JAK2 mutation directly promote platelets and granulocytes activation and indirectly initiate endothelial activation. Such interactions can provoke endothelial injury with...
Main Authors: | Ibrahim A Mahmood, Farqad B Hamdan, Waseem F Al-Tameemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Iraqi Journal of Hematology |
Subjects: | |
Online Access: | http://www.ijhonline.org/article.asp?issn=2072-8069;year=2019;volume=8;issue=2;spage=74;epage=80;aulast=Mahmood |
Similar Items
-
Role of endothelial dysfunction in relation to prothrombogenesis in polycythemia vera
by: Ibrahim A Mahmood, et al.
Published: (2018-01-01) -
Heat-shock protein 70 and pentraxin-3 inflammatory biomarkers: Implication for thrombosis in polycythemia vera
by: Ibrahim Abdullah Mahmood, et al.
Published: (2020-01-01) -
Polycythemia Vera: New Diagnostic Concept and Its Types
by: AM Kovrigina, et al.
Published: (2016-04-01) -
Cluster-Like Headache Revealing Polycythemia Vera: A Case Report
by: Cyprian Popescu
Published: (2020-06-01) -
Diagnosis of latent polycythemia vera: A clinician’s opinion
by: A L Melikian, et al.
Published: (2016-07-01)